In contrast, the genes encoding signaling molecules upstream from JNK (e.g. IRAK4, CDC42, KRAS) were up-regulated during OM, suggesting increased involvement of JNK signaling during the course of OM. The gene discussed is KRAS; the disease is ocular melanoma.